Most of the scariest side effects of weight-loss drugs like Ozempic, Wegovy, and Zepbound have been gastrointestinal.

Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a ...

Doctors explain why headaches are popular among Wegovy and Ozempic patients and how to treat and prevent them, including ...

GLP-1 agonists like Wegovy, Ozempic, and Mounjaro might benefit heart and brain health—but research suggests they might also ...

Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.

She began using Wegovy, the version of Ozempic approved for weight loss, after struggling with obesity. She reveals which ...

“GLP-1 drugs don’t just curb appetite – they dull the desire to drink at a metabolic level. With cravings suppressed and tolerance lowered. GLP-1 users report skipping drinks, stopping earlier or ...

Marc Mckee has spoken about his experience losing nine stone in 10 months on Mounjaro, revealing the surprising psychological ...

Novo Nordisk submits a higher 7.2 mg dose of Wegovy for EMA approval, backed by trials showing 21% weight loss in obesity and ...

Experts are warning anyone experiencing GLP-1 drug side effects to report them after launching an investigation into their safety.

These can include weight loss, loss of appetite, yellowing of the skin, vomiting or nausea, and the symptoms of diabetes ...

Sir Keir Starmer has set out his 10-year-plan to reform the NHS in England, based on a shift from hospitals to neighbourhood ...